Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 00:00 | 05 Jul | 937.70 |
7.35 (0.79%) |
OPEN
940.00 |
HIGH
948.95 |
LOW
931.25 |
| NSE 00:00 | 05 Jul | 937.40 |
6.75 (0.73%) |
OPEN
935.00 |
HIGH
949.65 |
LOW
930.25 |
| OPEN | 940.00 |
| PREVIOUS CLOSE | 930.35 |
| VOLUME | 14268 |
| 52-Week high | 1083.15 |
| 52-Week low | 850.00 |
| P/E | 25.58 |
| Mkt Cap.(Rs cr) | 75,663 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cipla Ltd. (CIPLA) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 835.55 | 0.83 | 966.90 | 664.10 | 200473.51 |
| Divi's Lab. | 3610.35 | -0.77 | 5425.00 | 3365.10 | 95836.74 |
| Cipla | 937.70 | 0.79 | 1083.15 | 850.00 | 75663.02 |
| Dr Reddy's Labs | 4389.45 | 0.54 | 5613.65 | 3655.00 | 73058.01 |
| Apollo Hospitals | 3816.50 | 1.16 | 5930.70 | 3365.90 | 54873.64 |
| Torrent Pharma. | 2891.85 | -0.45 | 3304.45 | 2485.00 | 48935.89 |
| Gland Pharma | 2530.00 | -2.41 | 4350.00 | 2498.00 | 41669.10 |
| Piramal Enterp. | 1695.75 | 0.87 | 3013.00 | 1561.00 | 40469.07 |
| Abbott India | 18630.80 | -1.63 | 23902.30 | 15525.00 | 39590.45 |
| Biocon | 313.70 | 0.80 | 414.30 | 305.00 | 37662.82 |
| Zydus Lifesci. | 361.35 | 0.36 | 651.75 | 319.40 | 36991.40 |
| Alkem Lab | 3050.40 | 0.33 | 4067.70 | 2835.00 | 36467.53 |
| Max Healthcare | 366.45 | 0.19 | 472.60 | 257.05 | 35532.09 |
| Aurobindo Pharma | 533.30 | 0.88 | 1008.75 | 503.40 | 31246.05 |
| Lupin | 627.40 | -0.21 | 1193.00 | 583.05 | 28521.60 |
| Glaxosmi. Pharma | 1541.40 | 0.64 | 1917.00 | 1433.05 | 26112.86 |
| Laurus Labs | 463.30 | -1.19 | 723.55 | 433.20 | 24895.43 |
| Ipca Labs. | 927.90 | 1.05 | 1383.55 | 831.40 | 23540.82 |
| Syngene Intl. | 550.85 | -1.04 | 699.95 | 508.10 | 22112.77 |
| Pfizer | 4112.55 | 0.21 | 6164.80 | 4056.00 | 18814.92 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
